CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity

Area of Science:

• Microbiology
• Molecular Biology
• Immunology

Background:

• CRISPR-Cas systems are prokaryotic immune mechanisms that use spacer sequences to recognize and eliminate invading nucleic acids.
• Spacer acquisition, a key step in CRISPR immunity, involves integrating foreign DNA fragments into the host CRISPR locus.
• The timing and specific genomic locations of spacer acquisition during viral infection remain largely uncharacterized.

Purpose of the Study:

• To investigate the temporal dynamics of spacer acquisition in Staphylococcus aureus during bacteriophage infection.
• To determine which stages of the viral life cycle are responsible for spacer acquisition.
• To assess the impact of spacer acquisition location on the efficacy of CRISPR-Cas9 immunity.

Main Methods:

• Infection of Staphylococcus aureus strains with CRISPR-Cas9 systems using staphylococcal bacteriophage ϕ12.
• Tracking of new spacer acquisition using mutant phages and analysis of injected DNA.
• Evaluation of CRISPR-Cas9 mediated immunity based on the origin of acquired spacers.

Main Results:

• Spacer acquisition occurred immediately after bacteriophage infection, preferentially from the cos site of the injected viral DNA.
• The majority of spacers were acquired during the DNA injection phase, not during replication or packaging.
• Spacers derived from early-injected genomic regions conferred superior immunity compared to those from late-injected regions.

Conclusions:

• CRISPR-Cas systems strategically acquire spacers early in the phage infection cycle to maximize immune response effectiveness.
• The timing and location of spacer acquisition are critical for optimizing CRISPR-mediated bacterial defense against phages.
• Understanding the interplay between phage life cycle and CRISPR immunity provides insights into prokaryotic defense strategies.